Skip to main content
Top
Published in: Rheumatology International 4/2009

01-02-2009 | Original Article

Is leptin a significant predictor of bone mineral density in postmenopausal Turkish women?

Authors: Serdar Oguz, Omer L. Tapisiz, Hakan Aytan, Ilker Gunyeli, Savas Erdem, Gorkem Tuncay, Umit Bilge, Leyla Mollamahmutoglu

Published in: Rheumatology International | Issue 4/2009

Login to get access

Abstract

The objective of the present study was to investigate the relationship between leptin and bone mineral density in postmenopausal Turkish women. A total of 122 healthy postmenopausal women were enrolled in this cross-sectional study. Blood samples were obtained for analysis of serum leptin. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry at the lumbar spine, femoral neck and trochanter on the same day. Leptin levels was significantly correlated with BMD of L1–4 (P = 0.04), but not of femoral neck (P = 0.13), and trochanter (P = 0.39). However, Z scores of L1–4 (P = 0.009), femur neck (P = 0.009), and femur trochanter (P = 0.025) were positively correlated with leptin levels. In multiple linear regression analysis, leptin was not found to be a statistically significant independent predictor for BMD. Leptin was associated with BMD and Z scores at various body sites; however, it was not an independent predictor of BMD.
Literature
2.
go back to reference Hosoda K, Masuzaki H, Ogawa Y et al (1996) Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 221:234–239PubMedCrossRef Hosoda K, Masuzaki H, Ogawa Y et al (1996) Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 221:234–239PubMedCrossRef
4.
go back to reference Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638. doi:10.1210/en.140.4.1630 PubMedCrossRef Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL (1999) Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638. doi:10.​1210/​en.​140.​4.​1630 PubMedCrossRef
7.
go back to reference Weiss LA, Barrett-Connor E, von Muhlen D, Clark P (2006) Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study. J Bone Miner Res 21:758–764. doi:10.1359/jbmr.060206 PubMedCrossRef Weiss LA, Barrett-Connor E, von Muhlen D, Clark P (2006) Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study. J Bone Miner Res 21:758–764. doi:10.​1359/​jbmr.​060206 PubMedCrossRef
9.
go back to reference Goulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458. doi:10.1007/s002239900557 PubMedCrossRef Goulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458. doi:10.​1007/​s002239900557 PubMedCrossRef
10.
go back to reference Sahin G, Polat G, Bagis S et al (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 23:87–91PubMed Sahin G, Polat G, Bagis S et al (2003) Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Rheumatol Int 23:87–91PubMed
14.
go back to reference Chanprasertyothin S, Piaseu N, Chailurkit L, Rajatanavin R, Ongphiphadhanakul B (2005) Association of circulating leptin with bone mineral density in males and females. J Med Assoc Thai 88:655–659PubMed Chanprasertyothin S, Piaseu N, Chailurkit L, Rajatanavin R, Ongphiphadhanakul B (2005) Association of circulating leptin with bone mineral density in males and females. J Med Assoc Thai 88:655–659PubMed
17.
go back to reference Iwaniec UT, Shearon CC, Heaney RP, Cullen DM, Yee JA (1998) Leptin increases number of mineralized bone nodules in vitro. J Bone Miner Res 13:s212 Iwaniec UT, Shearon CC, Heaney RP, Cullen DM, Yee JA (1998) Leptin increases number of mineralized bone nodules in vitro. J Bone Miner Res 13:s212
21.
go back to reference Cornish J, Callon KE, Bava U et al (2001) The direct actions of leptin on bone cells increase bone strength in vivo: an explanation of low frequency fracture rates in obesity (abstract). Bone 28:S88 Cornish J, Callon KE, Bava U et al (2001) The direct actions of leptin on bone cells increase bone strength in vivo: an explanation of low frequency fracture rates in obesity (abstract). Bone 28:S88
23.
go back to reference Bassilana F, Susa M, Keller HJ et al (2000) Human mesenchymal stem cells undergoing osteogenic differentiation express leptin and functional leptin receptor (abstract). J Bone Miner Res 15:S378 Bassilana F, Susa M, Keller HJ et al (2000) Human mesenchymal stem cells undergoing osteogenic differentiation express leptin and functional leptin receptor (abstract). J Bone Miner Res 15:S378
Metadata
Title
Is leptin a significant predictor of bone mineral density in postmenopausal Turkish women?
Authors
Serdar Oguz
Omer L. Tapisiz
Hakan Aytan
Ilker Gunyeli
Savas Erdem
Gorkem Tuncay
Umit Bilge
Leyla Mollamahmutoglu
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0711-8

Other articles of this Issue 4/2009

Rheumatology International 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.